Resultats de la cerca - Jae‐Sook Ahn
- Mostrar 1 - 11 resultats de 11
-
1
-
2
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy per Tae‐Hyung Kim, Marc S. Tyndel, Hyeoung Joon Kim, Jae-Sook Ahn, Seung Hyun Choi, Hee Jeong Park, Yeo‐Kyeoung Kim, Soo Young Kim, Jeffrey H. Lipton, Zhaolei Zhang, Dennis Dong Hwan Kim
Publicat 2016Artigo -
3
Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma per Ga‐Young Song, Sung‐Hoon Jung, Kihyun Kım, Seok Jin Kim, Sang Eun Yoon, Ho Sup Lee, Mihee Kim, Seo‐Yeon Ahn, Jae‐Sook Ahn, Deok‐Hwan Yang, Hyeoung‐Joon Kim, Je‐Jung Lee
Publicat 2020Artigo -
4
Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukem... per J.-H. Yoon, Ho‐Young Yhim, Jae‐Yong Kwak, Jae‐Sook Ahn, Deok‐Hwan Yang, J.-J. Lee, Se Joo Kim, J.-S. Kim, So Jeong Park, Chul Won Choi, Hyeon‐Seok Eom, S.-K. Park, Soo Young Choi, S.-H. Kim, D.-W. Kim, S. Lee
Publicat 2016Artigo -
5
Myelodysplastic Syndromes: A More Global 5-Hydroxymethylcytosine Deficiency Disorder Than Suggested By the Presence of TET2 Mutations per Carmelo Gurnari, Simona Pagliuca, Yihong Guan, Courtney E. Hershberger, Ying Ni, Jaymeson Gordon, Hetty E. Carraway, Richard A. Padgett, Diego F. Coutinho, Ilana Zalcberg, Jae‐Sook Ahn, Hyeoung‐Joon Kim, Dennis Dong Hwan Kim, Mark D. Minden, Joop H. Jansen, Babal K. Jha, Torsten Haferlach, Jaroslaw P. Maciejewski, Valeria Visconte
Publicat 2021Artigo -
6
DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Tr... per Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, Seun-Shin Lee, Sung‐Hoon Jung, Deok‐Hwan Yang, Je‐Jung Lee, Nan Young Kim, Seung Hyun Choi, Chul Won Jung, Jun‐Ho Jang, Hee‐Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Sung‐Hyun Kim, Dennis Dong Hwan Kim
Publicat 2015Artigo -
7
<i>TET2</i> mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes per Carmelo Gurnari, Simona Pagliuca, Yihong Guan, Vera Ademà, Courtney E. Hershberger, Ying Ni, Hassan Awada, Sunisa Kongkiatkamon, Misam Zawit, Diego F. Coutinho, Ilana Zalcberg, Jae-Sook Ahn, Hyeoung‐Joon Kim, Dennis Dong Hwan Kim, Mark D. Minden, Joop H. Jansen, Manja Meggendorfer, Claudia Haferlach, Babal K. Jha, Torsten Haferlach, Jaroslaw P. Maciejewski, Valeria Visconte
Publicat 2021Artigo -
8
Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse per Tae‐Hyung Kim, Joon Ho Moon, Jae-Sook Ahn, Yeo‐Kyeoung Kim, Seung-Shin Lee, Seo-Yeon Ahn, Sung‐Hoon Jung, Deok‐Hwan Yang, Je‐Jung Lee, Seung Hyun Choi, Ja-Yeon Lee, Marc S. Tyndel, Myung‐Geun Shin, Yoo Jin Lee, Sang Kyun Sohn, Seong-Kyu Park, Zhaolei Zhang, Hyeoung‐Joon Kim, Dennis Dong Hwan Kim
Publicat 2018Artigo -
9
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) per Yu Ri Kim, Jin Seok Kim, Yoo Hong Min, Dok Hyun Yoon, Ho‐Jin Shin, Yeung‐Chul Mun, Yong Park, Young Rok, Seong Hyun Jeong, Joon Seong Park, Sung Yong Oh, Suee Lee, Eunkyung Park, Joung-Soon Jang, Won Sik Lee, Hwe-Won Lee, Hyeon‐Seok Eom, Jae‐Sook Ahn, Jae-Heon Jeong, Sun Kyung Baek, Seok Jin Kim, Won Seog Kim, Cheolwon Suh
Publicat 2012Artigo -
10
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia per Ga‐Young Song, Hyeon-Jong Kim, Tae‐Hyung Kim, Seo‐Yeon Ahn, Sung‐Hoon Jung, Mihee Kim, Deok‐Hwan Yang, Je‐Jung Lee, Mi Yeon Kim, June‐Won Cheong, Chul Won Jung, Jun Ho Jang, Hee‐Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Seong Kyu Park, Sung‐Hyun Kim, Chang Kyun Choi, Hyeoung‐Joon Kim, Jae‐Sook Ahn, Dennis Dong Hwan Kim
Publicat 2024Artigo -
11
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia per Dae‐Young Kim, Young‐Don Joo, Sung-Nam Lim, Sung-Doo Kim, Jung‐Hee Lee, Je‐Hwan Lee, Dong Hwan Kim, Kihyun Kım, Chul Won Jung, Inho Kim, Sung‐Soo Yoon, Seonyang Park, Jae‐Sook Ahn, Deok‐Hwan Yang, Je‐Jung Lee, Ho Sup Lee, Yang Soo Kim, Yeung‐Chul Mun, Hawk Kim, Jae Hoo Park, Joon Ho Moon, Sang Kyun Sohn, Sang Min Lee, Won Sik Lee, Kyoung Ha Kim, Jong-Ho Won, Myung Soo Hyun, Jinny Park, Jae Hoon Lee, Ho‐Jin Shin, Joo-Seop Chung, Hyewon Lee, Hyeon‐Seok Eom, Gyeong Won Lee, Young‐Uk Cho, Seongsoo Jang, Chan‐Jeoung Park, Hyun‐Sook Chi, Kyoo‐Hyung Lee
Publicat 2015Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Myeloid leukemia
Oncology
Biology
Gene
Genetics
Leukemia
Cancer research
Mutation
Transplantation
Chemotherapy
Hematopoietic stem cell transplantation
Immunology
Myeloid
Acute lymphocytic leukemia
Biochemistry
Bone marrow
Cancer
Chemistry
Chemotherapy regimen
Gastroenterology
Imatinib
Intensive care medicine
Lymphoblastic Leukemia
Myelodysplastic syndromes
Surgery
Adrenal gland
Adverse effect
Autologous stem-cell transplantation